Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey

Heart and Vessels

Volumn 19, Issue 4, 2004, Pages 164-166

  Ayyildiz, Orhan ^a   Kalkanli, Sevgi ^a   Batun, Sabri ^a   Aybak, Mehmet ^a   Isikdogan, Abdurrahman ^a   Tiftik, Naci ^a   Bolaman, Zahit ^b   Soker, Murat ^a   Muftuoglu, Ekrem ^a  

^a DICLE UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

LightCycler polymerase chain reaction; Prothrombin G20210A gene mutation; Venous thrombosis

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; GUANINE; PROTHROMBIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; GENETIC RISK; HETEROZYGOSITY; HUMAN; INCIDENCE; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SAFETY; SEX DIFFERENCE; TURKEY (REPUBLIC);

EID: 4344685226     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-003-0760-6     Document Type: Article

References (19)

1. Rosendaal FR (1999) Risk factors for venous thrombotic disease. Thromb Haemost 82:610-619
2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703
3. Cakir O, Ayyildiz O, Oruc A, Eren N (2002) A young adult with coronary artery and jugular vein thrombosis: a case report of combined protein S and protein C deficiency. Heart Vessels 17:74-76
4. Hagstrom JN, Walter J, Langner RB, Amatniek JC, Manno CS, High KA (1998) Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 133:771-781
5. Griffin JH, Evatt B, Wideman C, Fernandez JA (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989-1993
6. Nauck M, Marz M, Weiland H (2000) Evaluation of the Roche diagnostics LightCycler-Factor V Leiden mutation detection kit and the LightCycler-Prothrombin mutation detection kit. Clin Biochem 33:213-216
7. von Ahsen N, Schutz E, Armstrong VW, Oellerich M (1999) Rapid detection of prothrombotic mutations of prothrombin (G20210A) factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem 45:694-696
8. Lay MJ, Wittwer CT (1997) Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin Chem 43:2262-2267
9. Souto JC, Coll I, Llobet D, del Rio E, Oliver A, Mateo J, Borrel M. Fontcuberta J (1998) The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 80:366-369
10. Bertina RM (1998) The prothrombin 20210 G to A variation and thrombosis. Curr Opin Hematol 5:339-342
11. Franco RF, Santos SE, Elion J, Tavella MH, Zago MA (1998) Prevalence of the G20210A polymorphism in the 3′-untranslated region of the prothrombin gene in different human populations. Acta Haematol 100:9-12
12. Bick RL (2003) Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C. and protein S defects. Hematol Oncol Clin North Am 17:9-36
13. Rosendaal FR, Doggen CJ, Zivclin A, Arrudda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79:706-708
14. Cattanco M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L (1999) The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb Res 93:1-8
15. Van der Meer FJM, Koster T, Vandenbroucke JP, Briet E, Rosendaal FR (1997) The Leiden Thrombophilia Study (LETS). Thromb Haemost 78:631-635
16. Boyanovsky B, Russev M, Ganev V, Penev M, Baleva M (2001) Prevalence of factor V Leiden and prothrombin 20210A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis. Blood Coagul Fibrinolysis 12:639-642
17. Gurgey A, Haznedaroglu IC, Egesel T, Buyukasik Y, Ozcebe OI, Sayinalp N, Dundar SV, Bayraktar Y (2001) Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis. Am J Hematol 67:107-111
18. Karakus Z, Baslamisli F, Gurkan E, Guvenc B, Unsal C, Tanriverdi K (2002) Thrombophilic risk factors in patients with venous thrombosis (in Turkish). XXIX National Congress of Hematology
19. Kalkanli S, Ayyildiz O, Tiftik N, Batun S, Isikdogan A, Ince H, Tekes S, Muftuoglu F (2004) Factor V Leiden mutation in venous thrombosis in southeast of Turkey. Angiology: in press